​

VistaGen Therapeutics Ownership | Who Owns VistaGen Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

VistaGen Therapeutics Ownership Summary

VistaGen Therapeutics is owned by 13.83% institutional investors, 0.25% insiders, and 85.92% retail investors. Tcg crossover management is the largest institutional shareholder, holding 0% of VTGN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 4.73% of its assets in VistaGen Therapeutics shares.

VTGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockVistaGen Therapeutics13.83%0.25%85.92%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tcg crossover management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tcg crossover management---

Top Buyers

HolderShares% AssetsChange
Tcg crossover management---2.68M

Top Sellers

HolderShares% AssetsChange
Tcg crossover management---2.68M

Sold Out

HolderChange
Tcg crossover management-2.68M

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20241-2,676,580-1316.67%----
Mar 31, 20241-2,676,580-910.98%--100.00%--
Dec 31, 20231-2,676,580-9-1---
Jun 30, 20231-98.78%4,900-99.99%-0.02%--100.00%1-94.44%
Mar 31, 202382-5.75%38,404,266-5.92%-143.02%35-18-18.18%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.28M4.73%-
Vanguard Institutional Extnd Mkt Idx Tr483.66K1.79%-
Fidelity Extended Market Index132.01K0.49%-27.35K
AdvisorShares Psychedelics ETF89.58K0.33%-
BlackRock Extended Equity Market K61.89K0.23%-26.00
iShares Micro-Cap ETF61.34K0.23%-
A4Investments SICAV SIF ACCI IlanaA2EURH60.00K0.22%-
Fidelity Total Market Index47.88K0.18%-118.00
Fidelity Series Total Market Index30.42K0.11%-6.39K
Vifag 2002 SICAV30.00K0.11%-

Recent Insider Transactions

DateNameRoleActivityValue
Aug 07, 2023COMMODORE CAPITAL LP-Buy$17.96M
Aug 18, 2022GIN JERRY B Buy$17.87K
Aug 17, 2022Adler Reid G. CHIEF LEGAL OFFICERBuy$50.91K
Aug 17, 2022Singh Shawn CHIEF EXECUTIVE OFFICERBuy$103.20K
Jul 12, 2022Shah Nimish P Sell$53.40K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q4--
2023 Q31-
2023 Q2--
2022 Q4--

VTGN Ownership FAQ

Who Owns VistaGen Therapeutics?

VistaGen Therapeutics shareholders are primarily institutional investors at 13.83%, followed by 0.25% insiders and 85.92% retail investors. The average institutional ownership in VistaGen Therapeutics's industry, Biotech Stocks , is 47.04%, which VistaGen Therapeutics falls below.

Does Blackrock own VistaGen Therapeutics?

BlackRock is not among the top 10 institutional shareholders of VistaGen Therapeutics.

Who is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested?

Tcg crossover management is VistaGen Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 VistaGen Therapeutics shares, valued at 0$.

Who is the top mutual fund holder of VistaGen Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of VistaGen Therapeutics shares, with 4.73% of its total shares outstanding invested in 1.28M VistaGen Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools